Bioequivalence and Bioavailability Forum • ANVISA guidelines for two-stage design

ANVISA guidelines for two-stage design [Two-Stage / GS Designs]

posted by Mauricio Sampaio – Brazil, 2020-02-12 18:04 (1321 d 15:02 ago) – Posting: # 21166
Views: 5,613

Hi nobody

❝ "Ermmm...... WHAT???? :-D :party: '

Sorry! Change to: unknowlegement of intra-individual variability

Complete thread:

ANVISA guidelines for two-stage design Mauricio Sampaio 2020-02-11 20:52 [Two-Stage / GS Designs]
- Brainless copy-and-paste-devil Helmut 2020-02-12 02:26
  - Brainless copy-and-paste-devil Mauricio Sampaio 2020-02-12 17:33
- ANVISA guidelines for two-stage design ElMaestro 2020-02-12 08:27
  - ANVISA guidelines for two-stage design nobody 2020-02-12 08:49
  - ANVISA guidelines for two-stage design Helmut 2020-02-12 13:12
  - ANVISA guidelines for two-stage designMauricio Sampaio 2020-02-12 17:04
  - ANVISA guidelines for two-stage design Mauricio Sampaio 2020-02-12 17:11
- ANVISA guidelines for two-stage design ElMaestro 2020-02-12 21:54
  - crap Helmut 2020-02-15 17:53
    - crap Mauricio Sampaio 2020-02-16 05:01
      - crap Helmut 2020-02-16 15:43
        
        crap d_labes 2020-02-16 19:34
        
        Explained crap remains crap Helmut 2020-02-17 12:49
        
        Proposed changes Mauricio Sampaio 2020-02-17 13:50
        
        Proposed changes Helmut 2020-02-17 14:16

Admin contact
22,759 posts in 4,775 threads, 1,628 registered users;
16 visitors (0 registered, 16 guests [including 6 identified bots]).
Forum time: 10:07 CEST (Europe/Vienna)

Whenever a theory appears to you as the only possible one,
take this as a sign that you have neither understood the theory
nor the problem which it was intended to solve. Karl R. Popper

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC

Ing. Helmut Schütz